Study Achieves Primary Endpoint News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Achieves Primary Endpoint. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Achieves Primary Endpoint Today - Breaking & Trending Today

Viking Therapeutics Announces Positive Top-Line Results from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)

Published: May 16, 2023

Study Achieves Primary Endpoint, Demonstrating Statistically Significant Reductions in Liver Fat from Baseline to Week 12 in Patients Receiving VK2809 as...

Source: prnewswire.com

Related Topics:

Prnewswire Viking Therapeutics IncLigand Pharmaceuticals IncorporatedTherapeutics IncStudy Achieves Primary EndpointLiver FatPatients ReceivingMean Liver Fat Reduction ObservedTreated PatientsPatients ExperiencedRelative ReductionSignificant ReductionsAtherogenic Lipoproteins ObservedSimilar AmongCall ScheduledLiver Fat ContentCall TodayInvestor RelationsViking TherapeuticsLigand Pharmaceuticals